RecruitingNot Applicable

Management of Combined Patellofemoral and Medial Compartment Knee Osteoarthritis

Egypt40 participantsStarted 2024-12-01

Plain-language summary

Evaluate the results of management of patients with patellofemoral and medial compartment knee osteoarthritis with open wedge high tibial osteotomy with or without arthroscopic partial lateral patellar facetectomy

Who can participate

Age range

35 Years – 60 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

. Age 35-60years
. Mild to moderate TFOA (G I-II-III) Kellgren-Lawrence (KL) scale (16)
. Anterior knee pain (PFOA)
. No involvement of the lateral compartment
. range of motion of at least 120° flexion
. Body mass index (BMI) \<30kg/m2
. varus angle degree \<10°

Exclusion criteria

. advanced case of TFOA (G VI KL scale), which requires total knee replacement.
. flexion deformity ≥15°
. inflammatory disease (such as rheumatoid arthritis).

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Knee injury and Osteoarthritis Outcome Score (KOOS)

Timeframe: during the follow-up period for 2years (2 weeks, 4 weeks, 6 weeks, 6 months, 1 year, and 2 years postoperatively)

Kujala Score (Anterior Knee Pain Scale - AKPS)

Timeframe: during the follow-up period for 2 years (2 weeks, 4 weeks, 6 weeks, 6 months, 1 year, and 2 years postoperatively)

Trial details

NCT IDNCT06762171

SponsorSohag University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-06

Contact for this trial

Ahmed Tarek Ahmed, Assistant lecturer

01033667677 Ahmed.Tarek@med.sohag.edu.eg

View on ClinicalTrials.gov More Knee Osteoarthritis trials